Mobilizing community pharmacists as catalysts for deprescribing

Deprescribing can minimize harm associated with polypharmacy. Community pharmacists can play a role; this project aims to explore and build their capacity to integrate deprescribing into their workflow and to facilitate communication with patients and prescribers. We will work with four community pharmacies and stakeholders from pharmacy organizations and insurers to develop a viable business model that helps pharmacists integrate deprescribing into their practices.

This one-year project will involve observations and regular meetings to quantify opportunities for deprescribing, describe activities and processes associated with deprescribing guideline use and hone workflow processes over time. We aim to build capacity for future scale-up and evaluation.

Lead: Dr. Barbara Farrell

Co-investigators: Dr. James Conklin, Dr. Lisa Dolovich, Dr. Lisa McCarthy, Dr. Lalitha Raman-Wilms

Contact: deprescribing@bruyere.org

Funder (2016-2017): Canadian Foundation for Pharmacy